Skip to main content
All lobbying filings

INDIVIOR INC

Lobbying for INDIVIOR INC

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $250,000.00 expenses · posted Jul 20, 2026

Official filing document

 Lobbying activity 1
Health Issues

Issues related to regaining status for long acting injectables on the BOP formulary, and changes to CMS bundled payments.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem